Vivo Capital’s Genetron Holdings Limited ADS GTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,708,056
Closed -$10.9M 46
2024
Q1
$10.9M Hold
2,708,056
0.86% 26
2023
Q4
$9.97M Sell
2,708,056
-2
-0% -$7 0.82% 25
2023
Q3
$105M Hold
2,708,058
11.46% 1
2023
Q2
$7.56M Hold
2,708,058
0.52% 28
2023
Q1
$105M Hold
2,708,058
7.26% 2
2022
Q4
$9.1M Hold
2,708,058
1.05% 22
2022
Q3
$6.35M Hold
2,708,058
0.7% 34
2022
Q2
$13.8M Buy
2,708,058
+237,532
+10% +$1.22M 1.39% 18
2022
Q1
$16.2M Buy
2,470,526
+357,239
+17% +$3.91M 1.12% 19
2021
Q4
$38.7M Hold
2,113,287
2.33% 11
2021
Q3
$87.8M Hold
2,113,287
3.94% 8
2021
Q2
$128M Hold
2,113,287
5.53% 7
2021
Q1
$136M Hold
2,113,287
4.78% 7
2020
Q4
$88.8M Hold
2,113,287
3.96% 7
2020
Q3
$75.7M Hold
2,113,287
4.37% 6
2020
Q2
$76.5M Buy
+2,113,287
New +$85.7M 5.49% 4

Vivo Capital's GTH Position: Q2 2024 in Review

Vivo Capital sold out of Genetron Holdings Limited ADS (GTH) in Q2 2024, closing a stake of 2,708,056 shares — an estimated $10.9M sold.

Vivo Capital first reported a position in GTH in Q2 2020 and held it in 16 quarters. The position peaked at $136M in Q1 2021. 0 funds tracked by Wall St. Rank hold GTH as of Q2 2024.

  • Vivo Capital reported no remaining Genetron Holdings Limited ADS position as of Q2 2024 after selling out during the quarter.
  • Vivo Capital sold 2,708,056 Genetron Holdings Limited ADS shares in Q2 2024, an estimated $10.9M.
  • Vivo Capital first reported a position in Genetron Holdings Limited ADS in Q2 2020 and held it in 16 quarters.
  • Vivo Capital's Genetron Holdings Limited ADS position peaked at $136M in Q1 2021.
  • 0 funds tracked by Wall St. Rank held Genetron Holdings Limited ADS as of Q2 2024.

Based on Vivo Capital's 13F filing for Q2 2024, filed 14 Aug 2024.